BROOMFIELD, Colo., Dec. 15, 2010 /PRNewswire/ — Lanx, Inc., a
privately held medical device company focused on developing and
commercializing innovative devices for spinal surgery, announced
the appointment of Dan W. Gladney as Chief Executive Officer and as
a member of the Board of Directors. He will assume the role on
January 10, 2011. Gladney has more than 25 years of experience in
the medical device industry, founding and leading companies in the
orthopedic and cardiology sectors.
Dr. Jeffrey Thramann, Co-founder and Chairman, said, “The Board
and the Lanx executive team are pleased to welcome Dan into this
leadership position. His specific operating experience as Chief
Executive of several emerging medical technology companies and
public company experience makes him an ideal fit for our
organization. We are confident he will make major contributions to
the next stage of our growth and expansion.”
Dan Gladney said, “I am excited to be joining the exceptional
team here at Lanx as the company develops into a world-class spine
company. The Company’s dedication to surgeon driven
innovation, impressive product portfolio, deep pipeline, and
talented employees will continue to serve as a strong platform for
growth and success. I look forward to working with the expanded
team to bring innovative solutions to surgeons and patients.”
Gladney was most recently Healthcare Operating Partner at
Norwest Equity Partners (NEP) where he was responsible for
strategic planning, business growth and corporate governance for
NEP portfolio companies and evaluating and executing new investment
opportunities for the firm.
Prior to joining NEP, Gladney served as President and CEO of
several successful medical device companies, including DGIMED
Ortho, Heart Leaflet Technologies and ACIST Medical Systems. He
also served as Chairman, CEO and President of Compex Technologies,
a publicly traded orthopedic and health and wellness electro
therapy company.
‘/>”/>
